Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wrafton Laboratories is a prominent UK-based contract development and manufacturing organization (CDMO) that specializes in the production of over-the-counter (OTC) medicines and healthcare products. Based in North Devon, the company operates as a major subsidiary of Perrigo Company plc, providing comprehensive services from formulation and analytical development to large-scale commercial manufacturing. Their product portfolio includes a wide array of formats such as tablets, capsules, liquids, creams, and ointments, serving both global pharmaceutical brands and private label retailers. The facility is recognized for its high regulatory standards, holding various GMP certifications to ensure the quality of essential consumer health products. Wrafton Laboratories plays a critical role in the UK healthcare supply chain, particularly in therapeutic areas like pain management, respiratory health, and gastrointestinal care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wrafton Lab.